Digital Oncology: The Future of Cancer Diagnosis and Treatment
Globally, 12% of venture funding in digital health in 2020 went to Oncology-focused ventures, which was more than any other therapeutic area, including mental health. Many oncology-focused ventures in the ecosystem seek to improve diagnosis and research to improve prevention and treatment within the healthcare value chain. How has the advancement of technology impacted the study, detection and treatment of cancer? Where do we see oncology and digital health moving? Join us as we dive into the world of oncology in a conversation with leading industry experts.
July 21 | 4.00 PM SGT
What you will get:
- Additional insights from Galen Growth’s Oncology report;
- A better understanding of the therapeutic focus area of Oncology;
- Real-world experience and cases;
- 25% off the Oncology report when you attend.
Dr. Dean Ho
Director, The N.1 Institute for Health
Dr. Huren Sivaraj
Co-Founder & CEO, Oncoshot
Founder & CEO, ONWARD Health Research
Dr. Hong-Ling Xue
Asia Pacific Medical Director, Solid Tumors, Novartis Oncology
COO, Galen Growth